These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

890 related items for PubMed ID: 17008110

  • 1. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
    Molnár I, Bokk A.
    Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
    [Abstract] [Full Text] [Related]

  • 2. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I.
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Serio M, Miccoli P.
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Detectable serum IgE levels in Graves' ophthalmopathy.
    Molnár I, Horváth S, Balázs C.
    Eur J Med Res; 1996 Sep 20; 1(11):543-6. PubMed ID: 9438158
    [Abstract] [Full Text] [Related]

  • 7. Four patients with hypothyroid Graves' disease.
    Starrenburg-Razenberg AJ, Castro Cabezas M, Gan IM, Njo TL, Rietveld AP, Elte JW.
    Neth J Med; 2010 Apr 20; 68(4):178-80. PubMed ID: 20421660
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
    Wakelkamp IM, Prummel MF, Wiersinga WM.
    Horm Metab Res; 2004 Jan 20; 36(1):44-7. PubMed ID: 14983406
    [Abstract] [Full Text] [Related]

  • 14. Soluble intercellular adhesion molecule-1 (sICAM-1) in Graves' disease.
    Balázs C, Kiss E.
    Acta Microbiol Immunol Hung; 1994 Jan 20; 41(4):451-6. PubMed ID: 7866729
    [Abstract] [Full Text] [Related]

  • 15. Thyrotropin binding inhibiting immunoglobulins (TBII) in Graves' disease, toxic nodular goitre and autoimmune thyroiditis.
    Wägar G, Mäkinen T, Lamberg BA, Gordin A, Apter L, Pekonen F.
    Ann Clin Res; 1982 Apr 20; 14(2):83-9. PubMed ID: 6184007
    [Abstract] [Full Text] [Related]

  • 16. Association of circulating antibodies against double-stranded and single-stranded DNA with thyroid autoantibodies in Graves' disease and Hashimoto's thyroiditis patients.
    Pedro AB, Romaldini JH, Americo C, Takei K.
    Exp Clin Endocrinol Diabetes; 2006 Jan 20; 114(1):35-8. PubMed ID: 16450315
    [Abstract] [Full Text] [Related]

  • 17. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
    Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Barani L, Ferrannini E, Serio M.
    Clin Endocrinol (Oxf); 2006 Feb 20; 64(2):189-95. PubMed ID: 16430719
    [Abstract] [Full Text] [Related]

  • 18. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K, De Bellis A, Li AW, Yamada M, Kubota S, Ackrell B, Wengrowicz S, Bellastella A, Bizzarro A, Sinisi A, Wall JR.
    J Clin Endocrinol Metab; 2000 Apr 20; 85(4):1641-7. PubMed ID: 10770210
    [Abstract] [Full Text] [Related]

  • 19. [Analysis of serum levels of ghrelin and obestatin in children and adolescents with autoimmune thyroid diseases].
    Sawicka B, Bossowski A, Urban M, Szalecki M, Wysocka J, Koput A, Zelazowska-Rutkowska B, Tobolczyk J, Skrzydło M, Rogowski F, Luba M.
    Pediatr Endocrinol Diabetes Metab; 2009 Apr 20; 15(1):20-7. PubMed ID: 19454185
    [Abstract] [Full Text] [Related]

  • 20. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H, Kuwert T, Lohmann T.
    Exp Clin Endocrinol Diabetes; 2004 Apr 20; 112(4):171-4. PubMed ID: 15127319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.